Share Prices & Company Research

Stockbroking

Physiomics

Current Price 2.60p Bid 2.50p Ask 2.60p Change 2.00%
Last Updated: 22/11/2019 12:27. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Physiomics plc is a solutions provider to the R&D based pharmaceutical and biotechnology industry with a focus on oncology. The Company's Virtual Tumour technology uses computer modelling to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Virtual Tumour has been confirmed by 55 projects, involving over 25 targets and 60 drugs, and has worked with clients such as Merck KGaA, Merck & Co, Bayer and Lilly. Based in Oxford UK, the Company works with clients worldwide to support their pre-clinical and clinical oncology development programs. Its team of scientists and computer modelling experts provide bespoke solutions encompassing data, analytics and insight.

Financial Highlights Year Ended 30/06/2019

Turnover
£0.78m
Operating Profit
£-0.20m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-18.57

Key Personnel

Dr James Simon Millen
Chief Executive Officer
Dr Christophe David Chassagnole
Chief Operating Officer
Dr Paul Bernard Harper
Non-Executive Chairman

Stock Details

EPIC
PYC
ISIN
GB00BDR6W943
Shares in Issue
71,910,394
Market cap
£1.87m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
2.55p
Bid Price
2.50p
Ask Price
2.60p
Volume
177503
Change Today
0.05p
% Change Today
2.00%
Open
2.60p
Previous Close
2.50p
Intraday High
2.60p
Intraday Low
2.52p
52 Week High
5.53p
52 Week Low
2.45p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Physiomics Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
0.0
0.0
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
0.0
0.0
Inventory
0.0
0.0
Trade & Receivables
0.3
0.2
Cash & Receivables
0.4
0.6
Other Current Assets & Assets Held for Resale
0.0
0.0
Total Assets
0.7
0.8

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Short Term Liabilities
0.1
0.1
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
0.1
0.1

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Net Assets
0.6
0.7

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Share Capital
1.2
1.2
Minority Interests
0.0
0.0
Retained Earnings
-6.0
-5.9
Share Premium Account
5.2
5.2
Other Equity
0.2
0.2
Total Equity
0.6
0.7

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Cashflow from Operating Activities
-0.1
-0.2
Cashflow Before Financing
-0.2
-0.2
Increase / Decrease in Cash
-0.2
0.4

Income (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2019
30 Jun 2018
Turnover
0.8
0.5
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
-0.2
-0.3
Pre-Tax Profit
-0.2
-0.3
Profit / Loss for the Year
-0.1
-0.2
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.